TARDBP and amyotrophic lateral sclerosis: In a wobbler mouse model with TDP-43 aggregation and ubiquitination, similar to the clinical pathology of ALS, edaravone significantly suppressed the decline of grip strength and muscle weight, as well as inhibiting spinal cord motor neuron degeneration [11].